Document and Entity Information
Document and Entity Information - shares | 6 Months Ended | |
Aug. 01, 2015 | Aug. 28, 2015 | |
Document And Entity Information [Abstract] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Period End Date | Aug. 1, 2015 | |
Document Fiscal Year Focus | 2,016 | |
Document Fiscal Period Focus | Q2 | |
Trading Symbol | ALOT | |
Entity Registrant Name | ASTRO MED INC /NEW/ | |
Entity Central Index Key | 8,146 | |
Current Fiscal Year End Date | --01-31 | |
Entity Filer Category | Smaller Reporting Company | |
Entity Common Stock, Shares Outstanding | 7,316,906 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Aug. 01, 2015 | Jan. 31, 2015 |
CURRENT ASSETS | ||
Cash and Cash Equivalents | $ 5,056 | $ 7,958 |
Securities Available for Sale | 13,274 | 15,174 |
Accounts Receivable, net | 15,223 | 14,107 |
Inventories | 13,937 | 15,582 |
Deferred Tax Assets | 2,636 | 2,629 |
Line of Credit Receivable | 150 | 173 |
Note Receivable | 250 | 255 |
Asset Held for Sale | 1,900 | 1,900 |
Prepaid Expenses and Other Current Assets | 3,087 | 4,140 |
Total Current Assets | 55,513 | 61,918 |
PROPERTY, PLANT AND EQUIPMENT | 38,080 | 36,823 |
Less Accumulated Depreciation | (29,175) | (28,444) |
Property, Plant and Equipment, net | 8,905 | 8,379 |
OTHER ASSETS | ||
Note Receivable | 69 | 256 |
Intangible Assets, net | 6,284 | 2,698 |
Goodwill | 4,522 | 991 |
Other | 103 | 88 |
Total Other Assets | 10,978 | 4,033 |
TOTAL ASSETS | 75,396 | 74,330 |
CURRENT LIABILITIES | ||
Accounts Payable | 3,369 | 3,155 |
Accrued Compensation | 2,522 | 3,302 |
Other Liabilities and Accrued Expenses | 2,464 | 2,343 |
Deferred Revenue | 419 | 621 |
Income Taxes Payable | 99 | 148 |
Total Current Liabilities | 8,873 | 9,569 |
Deferred Tax Liabilities | 72 | 83 |
Other Long Term Liabilities | 1,072 | 1,167 |
TOTAL LIABILITIES | 10,017 | 10,819 |
SHAREHOLDERS' EQUITY | ||
Common Stock, $0.05 Par Value, Authorized 13,000,000 shares; Issued 9,576,518 shares and 9,544,864 shares at August 1, 2015 and January 31, 2015, respectively | 479 | 477 |
Additional Paid-in Capital | 44,238 | 43,600 |
Retained Earnings | 41,091 | 39,735 |
Treasury Stock, at Cost, 2,293,606 shares at August 1, 2015 and January 31, 2015 | (19,602) | (19,602) |
Accumulated Other Comprehensive Loss | (827) | (699) |
TOTAL SHAREHOLDERS' EQUITY | 65,379 | 63,511 |
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | $ 75,396 | $ 74,330 |
Condensed Consolidated Balance3
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares | Aug. 01, 2015 | Jan. 31, 2015 |
Statement of Financial Position [Abstract] | ||
Common Stock, Par Value | $ 0.05 | $ 0.05 |
Common Stock, Shares Authorized | 13,000,000 | 13,000,000 |
Common Stock, Shares Issued | 9,576,518 | 9,544,864 |
Treasury Stock, Shares | 2,293,606 | 2,293,606 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Aug. 01, 2015 | Aug. 02, 2014 | Aug. 01, 2015 | Aug. 02, 2014 | |
Income Statement [Abstract] | ||||
Net Sales | $ 23,938 | $ 22,366 | $ 46,144 | $ 43,140 |
Cost of Sales | 14,092 | 12,777 | 27,268 | 24,915 |
Gross Profit | 9,846 | 9,589 | 18,876 | 18,225 |
Operating Expenses: | ||||
Selling and Marketing | 4,664 | 4,503 | 8,992 | 8,878 |
Research and Development | 1,565 | 1,479 | 3,361 | 2,850 |
General and Administrative | 1,783 | 1,443 | 3,241 | 2,634 |
Operating Expenses | 8,012 | 7,425 | 15,594 | 14,362 |
Operating Income, net | 1,834 | 2,164 | 3,282 | 3,863 |
Other Income (Expense) | 21 | 83 | 254 | (38) |
Income before Income Taxes | 1,855 | 2,247 | 3,536 | 3,825 |
Income Tax Provision | 687 | 812 | 1,158 | 1,261 |
Net Income | $ 1,168 | $ 1,435 | $ 2,378 | $ 2,564 |
Net Income per Common Share-Basic: | $ 0.16 | $ 0.19 | $ 0.33 | $ 0.34 |
Net Income per Common Share-Diluted: | $ 0.16 | $ 0.18 | $ 0.32 | $ 0.33 |
Weighted Average Number of Common Shares Outstanding: | ||||
Basic | 7,278 | 7,704 | 7,269 | 7,652 |
Diluted | 7,469 | 7,916 | 7,459 | 7,883 |
Dividends Declared Per Common Share | $ 0.07 | $ 0.07 | $ 0.14 | $ 0.14 |
Condensed Consolidated Stateme5
Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Aug. 01, 2015 | Aug. 02, 2014 | Aug. 01, 2015 | Aug. 02, 2014 | |
Statement of Comprehensive Income [Abstract] | ||||
Net Income | $ 1,168 | $ 1,435 | $ 2,378 | $ 2,564 |
Other Comprehensive Income (Loss), Net of Taxes and Reclassification Adjustments: | ||||
Foreign Currency Translation Adjustments | (122) | (133) | (113) | (41) |
Unrealized Holding Gain (Loss) on Securities Available for Sale | 4 | 1 | (15) | (2) |
Other Comprehensive Income (Loss) | (118) | (132) | (128) | (43) |
Comprehensive Income | $ 1,050 | $ 1,303 | $ 2,250 | $ 2,521 |
Condensed Consolidated Stateme6
Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 6 Months Ended | |
Aug. 01, 2015 | Aug. 02, 2014 | |
Cash Flows from Operating Activities: | ||
Net Income | $ 2,378 | $ 2,564 |
Adjustments to Reconcile Net Income to Net Cash Provided (Used) by Operating Activities: | ||
Depreciation and Amortization | 946 | 1,038 |
Share-Based Compensation | 444 | 259 |
Deferred Income Tax Provision (Benefit) | (18) | 51 |
Changes in Assets and Liabilities, net of acquisition: | ||
Accounts Receivable | (1,067) | (2,709) |
Inventories | 1,646 | (845) |
Income Taxes | 863 | (1,555) |
Accounts Payable and Accrued Expenses | (842) | (191) |
Other | (191) | (1,267) |
Net Cash Provided (Used) by Operating Activities | 4,159 | (2,655) |
Cash Flows from Investing Activities: | ||
Proceeds from Sales/Maturities of Securities Available for Sale | 5,003 | 7,900 |
Purchases of Securities Available for Sale | (3,127) | (3,945) |
Acquisition of RITEC's Ruggedized Printer Business | (7,360) | |
Release of Funds Held in Escrow From Sale of Grass | 1,800 | |
Proceeds Received on Disposition of Grass Inventory | 2,355 | |
Payments Received on Line of Credit and Note Receivable | 208 | 165 |
Additions to Property, Plant and Equipment | (1,291) | (874) |
Net Cash Provided (Used) by Investing Activities | (6,567) | 7,401 |
Cash Flows from Financing Activities: | ||
Proceeds from Common Shares Issued Under Employee Benefit Plans and Employee Stock Option Plans, Net of Payment of Minimum Tax Withholdings | 197 | 903 |
Dividends Paid | (1,022) | (1,076) |
Net Cash Used by Financing Activities | (825) | (173) |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 331 | 285 |
Net Increase (Decrease) in Cash and Cash Equivalents | (2,902) | 4,858 |
Cash and Cash Equivalents, Beginning of Period | 7,958 | 8,341 |
Cash and Cash Equivalents, End of Period | 5,056 | 13,199 |
Supplemental Disclosures of Cash Flow Information: | ||
Cash Paid During the Period for Income Taxes, Net of Refunds | $ 264 | $ 2,776 |
Overview
Overview | 6 Months Ended |
Aug. 01, 2015 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Overview | (1) Overview Headquartered in West Warwick, Rhode Island, Astro-Med Inc. designs, develops, manufactures and distributes a broad range of specialty printers and data acquisition and analysis systems. Our products are distributed through our own sales force and authorized dealers in the United States. We also sell to customers outside of the United States primarily through our Company offices in Canada, Mexico, Europe and Southeast Asia as well as with independent dealers and representatives. Astro-Med, Inc. products are sold under the brand names Astro-Med ® ® Unless otherwise indicated, references to “Astro-Med,” the “Company,” “we,” “our,” and “us” in this Quarterly Report on Form 10-Q refer to Astro-Med, Inc. and its consolidated subsidiaries. |
Basis of Presentation
Basis of Presentation | 6 Months Ended |
Aug. 01, 2015 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | (2) Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission, and reflect all adjustments consisting of normal recurring adjustments which, in the opinion of management, are necessary for a fair presentation of the results of the interim periods included herein. These financial statements do not include all disclosures associated with annual financial statements and, accordingly, should be read in conjunction with footnotes contained in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2015. Results of operations for the interim periods presented herein are not necessarily indicative of the results that may be expected for the full year. The presentation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. Some of the more significant estimates relate to the allowances for doubtful accounts and credits, inventory valuation, impairment of long-lived assets and goodwill, income taxes, share-based compensation, accrued expenses and warranty reserves. Management’s estimates are based on the facts and circumstances available at the time estimates are made, past historical experience, risk of loss, general economic conditions and trends, and management’s assessments of the probable future outcome of these matters. Consequently, actual results could differ from those estimates. Certain amounts in prior year’s financial statements have been reclassified to conform to the current year’s presentation. |
Principles of Consolidation
Principles of Consolidation | 6 Months Ended |
Aug. 01, 2015 | |
Accounting Policies [Abstract] | |
Principles of Consolidation | (3) Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. |
Acquisition
Acquisition | 6 Months Ended |
Aug. 01, 2015 | |
Business Combinations [Abstract] | |
Acquisition | (4) Acquisition On June 19, 2015, Astro-Med completed the acquisition of the ruggedized printer product line for civil and commercial aircraft from Rugged Information Technology Equipment Corporation (RITEC) under the terms of an Asset Purchase Agreement dated June 18, 2015. The products of RITEC consist of rugged printers for use in commercial aircraft sold primarily to aircraft manufacturers, tier one contractors and directly to airlines around the world. Astro-Med’s ruggedized printer product line is part of the Test & Measurement (T&M) product group and is reported as part of the T&M segment. The Company will begin shipment of the RITEC products in the third quarter of the current fiscal year. The purchase price of the acquisition was $7,360,000 which was funded using available cash and investment securities. Of the $7,360,000 purchase price, $750,000 is being held in escrow for twelve months following the acquisition date to support an indemnity to the Company in the event of any breach in the representations, warranties and covenants of RITEC. The assets acquired consist principally of accounts receivables and certain intangible assets. Acquisition related costs of approximately $90,000 are included in the general and administrative expenses in the Company’s consolidated statements of income for the three and six months ended August 1, 2015. The acquisition was accounted for under the acquisition method in accordance with the guidance provided by FASB ASC 805, “Business Combinations.” Astro-Med also entered into a Transition Services Agreement, under which RITEC will provide transition services and continue to manufacture products in the acquired product line for approximately six months until the Company transitions the manufacturing to its West Warwick, Rhode Island facility. Upon expiration of the Transition Services Agreement, Astro-Med will purchase any inventory held by RITEC at its book value (net of reserves), which the Company estimates will be approximately $100,000. Also as part of the Asset Purchase Agreement, Astro-Med entered into a License Agreement, which grants RITEC certain rights to use the intellectual property acquired by the Company in the design, development, marketing, manufacture, sale and servicing of ruggedized printers for aircraft sold to the military end-user market and printers sold to other non-aircraft market segments. RITEC will pay royalties equal to 7.5% of the sales price on all products sold into the military end-user aircraft market during the first five years of the License Agreement. The purchase price of the acquisition has been allocated on the basis of the fair value as follows: (In thousands) Accounts Receivable $ 50 Identifiable Intangible Assets 3,780 Goodwill 3,530 Total Purchase Price $ 7,360 The fair value of the intangible assets acquired was estimated by applying the income approach. This fair value measurement is based on significant inputs that are not observable in the market and therefore, represent a Level 3 measurement as defined in ASC 820, “Fair Value Measurement and Disclosure.” Key assumptions include (1) a weighted average cost of capital of 15.5%; (2) a range of earnings projections from $110,000-$700,000 and (3) a range of contract renewal probability from 0%-100%. Goodwill of $3,530,000, which is deductible for tax purposes, represents the excess of the purchase price over the estimated fair value assigned to the tangible and identifiable intangible assets acquired from RITEC. The carrying amount of the goodwill was allocated to the T&M segment of the Company. The following table reflects the fair value of the acquired identifiable intangible assets and related estimated useful lives: (In thousands) Fair Value Useful Life Customer Contract Relationships $ 2,830 10 Non-Compete Agreement 950 5 Total $ 3,780 Assuming the acquisition of RITEC occurred on February 1, 2014, the impact on net sales, net income and earnings per share would not have been material to the Company for the three and six months ended August 1, 2015 and August 2, 2014. |
Net Income Per Common Share
Net Income Per Common Share | 6 Months Ended |
Aug. 01, 2015 | |
Earnings Per Share [Abstract] | |
Net Income Per Common Share | (5) Net Income Per Common Share Basic net income per share is calculated by dividing net income by the weighted average number of shares outstanding during the period. Diluted net income per share is calculated by dividing net income by the weighted average number of shares and, if dilutive, common equivalent shares for stock options, unvested restricted stock awards and restricted stock units outstanding during the period. A reconciliation of the shares used in calculating basic and diluted net income per share is as follows: Three Months Ended Six Months Ended August 1, August 2, August 1, August 2, Weighted Average Common Shares Outstanding—Basic 7,278,329 7,703,782 7,268,745 7,652,000 Effect of Dilutive Options, Restricted Stock Awards and Restricted Stock Units 190,934 212,176 190,676 230,706 Weighted Average Common Shares Outstanding—Diluted 7,469,263 7,915,958 7,459,421 7,882,706 For the three and six months ended August 1, 2015 the diluted per share amounts do not reflect common equivalent shares outstanding of 424,100. For the three and six months ended August 2, 2014 the diluted per share amounts do not reflect common equivalent shares outstanding of 150,000. These outstanding common equivalent shares were not included due to their anti-dilutive effect. Anti-dilutive shares consist of those common stock equivalents that have either an exercise price above the average stock price for the period, or the common stock equivalent’s related average unrecognized stock compensation expense is sufficient to “buy back” the entire amount of shares. Restricted stock units which vest based upon achievement of performance targets are excluded from the diluted shares outstanding unless the performance targets have been met as of the end of the reporting period regardless of whether such performance targets are probable of achievement as of the end of the measurement period. |
Intangible Assets
Intangible Assets | 6 Months Ended |
Aug. 01, 2015 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Intangible Assets | (6) Intangible Assets Intangible assets are as follows: August 1, 2015 January 31, 2015 ($ In thousands) Gross Accumulated Net Gross Accumulated Net Intangible assets subject to amortization: Customer Contract Relationships (Miltope) $ 3,100 (580 ) $ 2,520 $ 3,100 $ (402 ) $ 2,698 Customer Contract Relationships (RITEC) 2,830 — 2,830 — — — Non-Compete Agreement (RITEC) 950 (16 ) 934 — — — Intangible assets, net $ 6,880 $ (596 ) $ 6,284 $ 3,400 $ (702 ) $ 2,698 There were no impairments to intangible assets during the periods ended August 1, 2015 and August 2, 2014. Amortization expense of $105,000 and $175,000 in regards to the above acquired intangibles has been included in the condensed consolidated statement of income for the three months ended August 1, 2015 and August 2, 2014, respectively. Amortization expense of $194,000 and $351,000 in regards to the above acquired intangibles has been included in the condensed consolidated statement of income for the six months ended August 1, 2015 and August 2, 2014, respectively. Estimated amortization expense for the next five years is as follows: (In thousands) Remainder of 2016 2017 2018 2019 2020 Estimated amortization expenses $ 305 $ 715 $ 774 $ 769 $ 802 |
Share-Based Compensation
Share-Based Compensation | 6 Months Ended |
Aug. 01, 2015 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Share-Based Compensation | (7) Share-Based Compensation Astro-Med has two equity incentive plans – the 2007 Equity Incentive Plan (the “2007 Plan”) and the 2015 Equity Incentive Plan (the “2015 Plan”). Under these plans, the Company may grant incentive stock options, non-qualified stock options, stock appreciation rights, time or performance based restricted stock units (“RSUs”), restricted stock awards (“RSAs”), and other stock-based awards to executives, key employees, directors and other eligible individuals. At August 1, 2015, 107,874 shares were available for grant under the 2007 Plan, of which 100,000 are reserved for stock options that the Company is obligated to issue to its CEO in fiscal years 2017 and 2018 pursuant to an Equity Incentive Award Agreement dated as of November 24, 2014 (the “CEO Equity Incentive Agreement”). The 2007 Plan will expire in May 2017. The 2015 Plan was approved by the Company’s shareholders at the 2015 annual meeting. The 2015 Plan authorizes the issuance of up to 500,000 shares (subject to adjustment for stock dividends and stock splits) and will expire in May 2025. At August 1, 2015, 240,000 shares were available for grant under the 2015 Plan. Options granted to employees under both Plans vest over four years and expire after ten years. The exercise price of each stock option will be established at the discretion of the Compensation Committee; however, any incentive stock options granted under the 2007 Plan, and all options granted under the 2015 Plan, must be at an exercise price of not less than the fair market value of the Company’s common stock on the date of grant. In March 2012 (fiscal year 2013), a portion of the Company’s executives’ long-term incentive compensation was awarded in the form of RSUs (“2013 RSUs”). The 2013 RSUs were earned based on the Company achieving specific thresholds of net sales and annual operating income as established under the fiscal 2013 Domestic Management Bonus Plan, and vested fifty percent on the first anniversary of the grant date and fifty percent on the second anniversary of the grant date provided that the grantee was employed on each vesting date by Astro-Med or an affiliate company. All such 2013 RSUs were earned and vested as of March 2014. In April 2013 (fiscal year 2014), the Company granted options and RSUs to officers (“2014 RSUs”). The 2014 RSUs will be earned and vest as follows: twenty-five percent vest on the third anniversary of the grant date, fifty percent vest upon the Company achieving its cumulative budgeted net sales target for fiscal years 2014 through 2016 (the “Measurement Period”), and twenty-five percent vest upon the Company achieving a target average annual ORONA (operating income return on net assets as calculated under the Domestic Management Bonus Plan) for the Measurement Period. The grantee may not sell, transfer or otherwise dispose of more than fifty percent of the common stock issued upon vesting of the 2014 RSUs until the first anniversary of the vesting date. On February 1, 2014, the Company accelerated the vesting of 4,166 of the 2014 RSUs held by Everett Pizzuti in connection with his retirement. None of the remaining 2014 RSUs, have vested as of August 1, 2015. In March 2015 (fiscal year 2016), the Company granted 50,000 options and 537 RSAs to its CEO pursuant to the CEO Equity Incentive Agreement, and 35,000 options to other key employees. The options and RSAs vest in four equal annual installments commencing on the first anniversary of the grant date. In May 2015 (fiscal year 2016), the Company granted an aggregate of 80,000 time-based and 155,000 performance-based RSUs (“2016 RSUs”) to certain officers of the Company. The time-based 2016 RSUs will vest in four equal annual installments commencing on the first anniversary of the grant date. The performance-based 2016 RSUs will vest over three years based upon the increase in net sales, if any, achieved each fiscal year relative to a three-year net sales increase goal. Performance-based 2016 RSUs that are earned based on organic revenue growth will be fully vested when earned, while those earned based on revenue growth via acquisitions will vest annually over a three-year period following the fiscal year in which the revenue growth occurs. Any performance-based 2016 RSUs that have not been earned at the end of the three-year performance period will be forfeited. Under the Plans, each non-employee director receives an automatic annual grant of ten-year options to purchase 5,000 shares of stock upon the adjournment of each shareholders meeting. Each such option is exercisable at the fair market value of the Company’s common stock as of the grant date, and vests immediately prior to the next succeeding shareholders’ meeting. During the second quarter of fiscal 2016, 25,000 options in total were granted to the non-employee directors. In addition to the automatic option grant, the Company has a Non-Employee Director Annual Compensation Program (the “Program”) which provides that each non-employee director is entitled to an annual cash retainer of $7,000 (the “Annual Cash Retainer”), plus $500 for each Board and committee meeting attended. In addition, the Chairman of the Board also receives an annual retainer of $6,000, and the Chairs of the Audit and Compensation Committees each receive an annual retainer of $4,000 (“Chair Retainer”). The non-employee directors may elect, for any fiscal year, to receive all or a portion of the Annual Cash Retainer and/or Chair Retainer (collectively the “Cash Retainer”) in the form of common stock of the Company, which will be issued under one of the Plans. If a non-employee director elects to receive all or a portion of the Cash Retainer in the form of common stock, such shares shall be issued in four quarterly installments on the first day of each fiscal quarter, and the number of shares of common stock to be issued shall be based on the fair market value of the Company’s common stock on the date such installment is payable. The common stock received in lieu of such Cash Retainer will be fully vested. However, a non-employee director who receives common stock in lieu of all or a portion of the Cash Retainer may not sell, transfer, assign, pledge or otherwise encumber the common stock prior to the first anniversary of the date on which such shares were issuable. In the event of the death or disability of a nonemployee director, or a change in control of the Company, any shares of common stock issued in lieu of such Cash Retainer, shall no longer be subject to such restrictions on transfer. During the first and second quarters of fiscal 2016, 698 and 722 shares, respectively, were awarded to non-employee directors in lieu of the Cash Retainer. In addition, under the Program, each non-employee director receives RSAs with a value equal to $20,000 (the “Equity Retainer”) upon adjournment of each annual shareholders’ meeting. If a non-employee director is first appointed or elected to the Board of Directors effective on a date other than at the annual shareholders’ meeting, on the date of such appointment or election, the director shall receive a pro rata award of restricted common stock having a value based on the number of days remaining until the next annual meeting. The Equity Retainer will vest on the earlier of 12 months after the grant date or the date immediately prior to the next annual meeting of the shareholders following the meeting at which such RSAs were granted. However, a non-employee director may not sell, transfer, assign, pledge or otherwise encumber the vested common stock prior to the second anniversary of the vesting date. In the event of the death or disability of a non-employee director, or a change in control of the Company, the RSAs shall immediately vest and shall no longer be subject to such restrictions on transfer. During the second quarter of fiscal 2016, 7,115 shares were awarded as the Equity Retainer to the non-employee directors. We account for compensation cost related to share-based payments based on the estimated fair value of the equity award. We estimate the fair value of each option on the date of grant using the Black-Scholes option-pricing model. Our estimate requires a number of complex and subjective assumptions including our stock price volatility, employee exercise patterns (expected life of the options), the risk-free interest rate and the Company’s expected future dividend yield. The stock price volatility assumption is based on the historical weekly price of our common stock over a period equivalent to the weighted average expected life of our options. Management evaluated whether there were factors during that period which were unusual and would distort the volatility figure if used to estimate future volatility and concluded that there were no such factors. In determining the expected life of the option grants, the Company has observed the actual terms of prior grants with similar characteristics and the actual vesting schedule of the grant and has assessed the expected risk tolerance of different option groups. The risk-free interest rate is based on the actual U.S. Treasury zero coupon rates for bonds matching the expected term of the option as of the option grant date. The dividend assumption is based upon the prior year’s average dividend yield. Reductions in compensation expense associated with forfeited options are estimated at the date of grant, and this estimated forfeiture rate is adjusted periodically based on actual forfeiture experience. Our accounting for share-based compensation for RSUs and RSAs is also based on the fair value method. The fair value of RSUs and RSAs is based on the closing market price of the Company’s common stock on the grant date. Share-based compensation expense was recognized as follows: Three Months Ended Six Months Ended August 1, August 2, August 1, August 2, (In thousands) Stock Options $ 70 $ 59 $ 144 $ 112 Restricted Stock Awards and Restricted Stock Units 228 67 296 144 Employee Stock Purchase Plan 3 2 4 3 Total $ 301 $ 128 $ 444 $ 259 Stock Options The fair value of stock options granted during the six months ended August 1, 2015 and August 2, 2014 was estimated using the following assumptions: August 1, August 2, Risk Free Interest Rate 1.6 % 1.6 % Expected Volatility 22.7 % 26.8 % Expected Life (in years) 5.0 5.0 Dividend Yield 2.0 % 2.0 % The weighted average fair value per share for options granted was $2.43 and $2.44 during the first and second quarters of fiscal 2016, respectively, compared to $2.93 and $2.84 during the first and second quarters of fiscal 2015. Aggregated information regarding stock options granted under the Plans for the six months ended August 1, 2015 is summarized below: Number of Options Weighted Average Weighted Average Aggregate Intrinsic Outstanding at January 31, 2015 656,011 $ 10.01 4.2 $ 3,225,000 Granted 110,000 13.98 Exercised (20,979 ) 8.24 Expired or canceled (2,093 ) 7.93 Forfeited (700 ) 12.61 Outstanding at August 1, 2015 742,239 $ 10.65 6.1 $ 2,396,104 Exercisable at August 1, 2015 475,776 $ 9.41 4.6 $ 2,109,647 As of August 1, 2015, there was $577,000 of unrecognized compensation expense related to unvested options, which may be recognized through March 2019. Restricted Stock Units (RSUs) and Restricted Stock Awards (RSAs) Aggregated information regarding RSUs and RSAs granted under the Plan for the six months ended August 1, 2015 is summarized below: RSAs & RSUs Weighted Average Unvested at January 31, 2015 72,245 $ 9.70 Granted 244,072 14.05 Vested (8,665 ) 13.95 Forfeited (2,800 ) 10.07 Unvested at August 1, 2015 304,852 $ 13.06 As of August 1, 2015, there was $1,658,000 of unrecognized compensation expense related to unvested RSUs and RSAs which may be recognized through May 2019. Employee Stock Purchase Plan Astro-Med has an Employee Stock Purchase Plan allowing eligible employees to purchase shares of common stock at a 15% discount from fair value on the date of purchase. A total of 247,500 shares were reserved for issuance under this plan. During the quarters ended August 1, 2015 and August 2, 2014, there were 1,293 and 1,592 shares, respectively, purchased under this plan. As of August 1, 2015, 54,980 shares remain available for purchase under the plan. |
Inventories
Inventories | 6 Months Ended |
Aug. 01, 2015 | |
Inventory Disclosure [Abstract] | |
Inventories | (8) Inventories Inventories are stated at the lower of cost (first-in, first-out) or market and include material, labor and manufacturing overhead. The components of inventories are as follows: August 1, 2015 January 31, 2015 (In thousands) Materials and Supplies $ 9,962 $ 10,600 Work-In-Process 816 765 Finished Goods 6,900 7,372 17,678 18,737 Inventory Reserve (3,741 ) (3,155 ) $ 13,937 $ 15,582 |
Income Taxes
Income Taxes | 6 Months Ended |
Aug. 01, 2015 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | (9) Income Taxes The Company’s effective tax rates for the period, which are based on the projected effective tax rate for the full year, are as follows: Three Months Ended Six Months Ended Fiscal 2016 37.0 % 32.7 % Fiscal 2015 36.1 % 33.0 % During the six months ended August 1, 2015, the Company recognized income tax expense of $1,158,000. The effective tax rate in this period was directly impacted by a $135,000 tax benefit related to the statute of limitations expiring on a previously uncertain tax position. During the six months ended August 2, 2014, the Company recognized income tax expense of $1,261,000 which included a tax benefit of $100,000 related to the favorable resolution of a previously uncertain tax position. As of August 1, 2015, the Company’s cumulative unrecognized tax benefits totaled $643,000 compared to $707,000 as of January 31, 2015. There were no other developments affecting unrecognized tax benefits during the period ended August 1, 2015. |
Note Receivable and Line of Cre
Note Receivable and Line of Credit Issued | 6 Months Ended |
Aug. 01, 2015 | |
Receivables [Abstract] | |
Note Receivable and Line of Credit Issued | (10) Note Receivable and Line of Credit Issued On January 30, 2012, the Company completed the sale of its label manufacturing operations in Asheboro, North Carolina to Label Line Ltd. The net sale price of $1,000,000 was received in the form of a promissory note issued by Label Line Ltd. and is secured by a first lien on various collateral, including the Asheboro plant and plant assets. The note bears interest at 3.75% and is payable in sixteen quarterly installments of principal and interest which commenced on January 30, 2013. As of August 1, 2015, $319,000 remains outstanding on this note which approximates its estimated fair value. The terms of the Asheboro sale also included an agreement for Astro-Med to provide Label Line Ltd. with additional financing in the form of a revolving line of credit in the amount of $600,000. This line of credit is secured by a first lien on various collateral of Label Line Ltd., including the Asheboro plant and plant assets, and bears interest at a rate equal to the United States prime rate plus an additional margin of two percent on the outstanding credit balance. The term of this revolving line of credit has been extended through January 31, 2016. As of August 1, 2015, $150,000 remains outstanding on this revolving line of credit. The estimated fair value of the line of credit approximates its carrying value. |
Segment Information
Segment Information | 6 Months Ended |
Aug. 01, 2015 | |
Segment Reporting [Abstract] | |
Segment Information | (11) Segment Information Astro-Med reports two segments: QuickLabel Systems (QuickLabel) and Test & Measurement (T&M). The Company evaluates segment performance based on the segment profit before corporate expenses. On June 19, 2015, Astro-Med completed the asset purchase of the ruggedized printer product line from RITEC. Astro-Med’s ruggedized printer product line is part of the T&M product group and is reported as part of the T&M segment. The Company will begin shipment of the RITEC products in the third quarter of the current fiscal year. Refer to Note 4, “Acquisition,” for further details. Summarized below are the Net Sales and Segment Operating Profit for each reporting segment: Three Months Ended Six Months Ended Net Sales Segment Operating Profit Net Sales Segment Operating Profit (In thousands) August 1, August 2, August 1, August 2, August 1, August 2, August 1, August 2, QuickLabel $ 17,100 $ 15,257 $ 2,720 $ 2,247 $ 32,744 $ 29,680 $ 4,698 $ 4,445 T&M 6,838 7,109 897 1,360 13,400 13,460 1,825 2,052 Total $ 23,938 $ 22,366 3,617 3,607 $ 46,144 $ 43,140 6,523 6,497 Corporate Expenses 1,783 1,443 3,241 2,634 Operating Income 1,834 2,164 3,282 3,863 Other Income (Expense)—Net 21 83 254 (38 ) Income Before Income Taxes 1,855 2,247 3,536 3,825 Income Tax Provision 687 812 1,158 1,261 Net Income $ 1,168 $ 1,435 $ 2,378 $ 2,564 |
Recent Accounting Pronouncement
Recent Accounting Pronouncements | 6 Months Ended |
Aug. 01, 2015 | |
Accounting Changes and Error Corrections [Abstract] | |
Recent Accounting Pronouncements | (12) Recent Accounting Pronouncements Inventory In July 2015, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2015-11, “Inventory (Topic 330).” ASU 2015-11 requires inventory to be measured at the lower of cost and net realizable value instead of at lower of cost or market. This guidance does not apply to inventory that is measured using last-in, first out (LIFO) or the retail inventory method but applies to all other inventory including inventory measured using first-in, first-out (FIFO) or the average cost method. ASU 2015-11 will be effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years (Q1 fiscal 2018 for Astro-Med) and should be applied prospectively. Early adoption is permitted as of the beginning of an interim or annual reporting period. Astro-Med is currently evaluating the effect of this new guidance on the Company’s consolidated financial statements. Revenue Recognition In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers (Topic 606).” ASU 2014-09 completes the joint effort by the FASB and International Accounting Standards Board (IASB) to improve financial reporting by creating common revenue recognition guidance for U.S. GAAP and International Financial Reporting Standards (IFRS). ASU 2014-09 applies to all companies that enter into contracts with customers to transfer goods or services. In July 2015, the FASB modified ASU 2014-09 to be effective for annual reporting periods beginning after December 15, 2017 (Q1 fiscal 2019 for Astro-Med), including interim periods within that reporting period. As modified, the FASB permits the adoption of the new revenue standard early, but not before the annual periods beginning after December 15, 2016. Entities have the choice to apply ASU 2014-09 either retrospectively to each reporting period presented or by recognizing the cumulative effect of applying ASU 2014-09 at the date of initial application and not adjusting comparative information. The Company is currently evaluating the requirements of ASU 2014-09 and has not yet determined its impact on the Company’s consolidated financial statements. No other new accounting pronouncements, issued or effective during the first six months of the current year, have had or are expected to have a material impact on our consolidated financial statements. |
Securities Available for Sale
Securities Available for Sale | 6 Months Ended |
Aug. 01, 2015 | |
Investments, Debt and Equity Securities [Abstract] | |
Securities Available for Sale | (13) Securities Available for Sale Pursuant to our investment policy, securities available for sale include state and municipal securities with various contractual or anticipated maturity dates ranging from one to 31 months. Securities available for sale are carried at fair value, with unrealized gains and losses reported as a component of accumulated other comprehensive income (loss) in shareholders’ equity until realized. Realized gains and losses from the sale of available for sale securities, if any, are determined on a specific identification basis. A decline in the fair value of any available for sale security below cost that is determined to be other than temporary will result in a write-down of its carrying amount to fair value. No such impairment charges were recorded for any period presented. All short-term investment securities have original maturities greater than 90 days. The fair value, amortized cost and gross unrealized gains and losses of securities available for sale are as follows: (In thousands) August 1, 2015 Amortized Cost Gross Unrealized Gross Unrealized Fair Value State and Municipal Obligations $ 13,273 $ 10 $ (9 ) $ 13,274 January 31, 2015 Amortized Cost Gross Unrealized Gross Unrealized Fair Value State and Municipal Obligations $ 15,150 $ 26 $ (2 ) $ 15,174 |
Fair Value
Fair Value | 6 Months Ended |
Aug. 01, 2015 | |
Fair Value Disclosures [Abstract] | |
Fair Value | (14) Fair Value We measure our financial assets at fair value on a recurring basis in accordance with the guidance provided in ASC 820, “Fair Value Measurement and Disclosures” which defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). In addition, ASC 820 establishes a three-tiered hierarchy for inputs used in management’s determination of fair value of financial instruments that emphasizes the use of observable inputs over the use of unobservable inputs by requiring that observable inputs be used when available. Observable inputs are inputs that reflect management’s belief about the assumptions market participants would use in pricing a financial instrument based on the best information available in the circumstances. The fair value hierarchy is summarized as follows: • Level 1—Quoted prices in active markets for identical assets or liabilities; • Level 2—Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and • Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Cash and cash equivalents, accounts receivables, accounts payable, accrued compensation and other expenses and income tax payable are reflected in the condensed consolidated balance sheet at carrying value, which approximates fair value due to the short term nature of the these instruments. Assets measured at fair value on a recurring basis are summarized below: (In thousands) August 1, 2015 Level 1 Level 2 Level 3 Total Money Market Funds (included in Cash and Cash Equivalents) $ 1,363 $ — $ — $ 1,363 State and Municipal Obligations (included in Securities Available for Sale) — 13,274 — 13,274 Total $ 1,363 $ 13,274 $ — $ 14,637 January 31, 2015 Level 1 Level 2 Level 3 Total Money Market Funds (included in Cash and Cash Equivalents) $ 3,028 $ — $ — $ 3,028 State and Municipal Obligations (included in Securities Available for Sale) — 15,174 — 15,174 Total $ 3,028 $ 15,174 $ — $ 18,202 For our money market funds and state and municipal obligations, we utilize the market approach to measure fair value. The market approach is based on using quoted prices for identical or similar assets. Non-financial assets such as goodwill, intangible assets, and property, plant and equipment are required to be measured at fair value only when impairment loss is recognized. The Company did not record an impairment loss related to these assets during the six month period ended August 1, 2015. |
Accumulated Other Comprehensive
Accumulated Other Comprehensive Loss | 6 Months Ended |
Aug. 01, 2015 | |
Equity [Abstract] | |
Accumulated Other Comprehensive Loss | (15) Accumulated Other Comprehensive Loss The changes in the balance of accumulated other comprehensive income (loss) by component are as follows: (In thousands) Foreign Currency Unrealized Holding Gain Total Balance at January 31, 2015 $ (714 ) $ 15 $ (699 ) Other Comprehensive Income (Loss) (113 ) (15 ) (128 ) Balance at August 1, 2015 $ (827 ) $ — $ (827 ) The amounts presented above in other comprehensive income (loss) are net of taxes, except for translation adjustments associated with our German subsidiary. |
Commitments and Contingencies
Commitments and Contingencies | 6 Months Ended |
Aug. 01, 2015 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | (16) Commitments and Contingencies Product Replacement Program In April 2013, tests conducted by the Company revealed that one of its suppliers had been using a non-conforming part in power supplies for certain models of Astro-Med’s Test & Measurement printers. No malfunctions have been reported by customers as a result of the non-conforming material. Upon identifying this issue, Astro-Med immediately suspended production of the printers, notified all customers and contacted the supplier who confirmed the problem. Astro-Med is continuing to work with its customers to replace the non-conforming material on existing printers with conforming material. The estimated costs associated with the replacement program were $672,000, which was based upon the number of printers shipped during the period the non-conforming material was used. Those estimated costs were recognized and recorded as a reserve in the first quarter of fiscal 2014. As of August 1, 2015, the Company had expended $358,000 in replacement costs which have been charged against this reserve. The remaining reserve amount of $314,000 is included in Other Accrued Expenses in the accompanying condensed consolidated balance sheet dated August 1, 2015. Astro-Med is currently receiving power supplies with compliant parts and has resumed printer production and shipments to customers. Since the supplier deviated from the agreed upon specifications for the power supply while providing certificates of conformance to the original specifications, in January 2014, Astro-Med received a non-refundable $450,000 settlement from the supplier for recovery of the costs and expense associated with this issue. In addition to this cash settlement, the Company is receiving lower product prices from the supplier through fiscal 2017. |
Line of Credit
Line of Credit | 6 Months Ended |
Aug. 01, 2015 | |
Debt Disclosure [Abstract] | |
Line of Credit | (17) Line of Credit The Company has a three-year, $10 million revolving line of credit available for ongoing working capital requirements, business acquisitions or general corporate purposes as needed. Any borrowings made under this line of credit bear interest at either a fluctuating base rate equal to the highest of (i) the Prime Rate, (ii) 1.50% above the daily one month LIBOR, and (iii) the Federal Funds Rate in effect plus 1.50% or at a fixed rate of LIBOR plus an agreed upon margin of between 0% and 2.25%, based on the Company’s funded debt to EBITDA ratio as defined in the agreement. The agreement provides for two financial covenant requirements, namely, Total Funded Debt to Adjusted EBITDA (as defined) of not greater than 3 to 1 and a Fixed Charge Coverage Ratio (as defined) of not less than 1.25 to 1, both measured at the end of each quarter on a rolling four quarter basis. As of August 1, 2015, there have been no borrowings against this line of credit and the Company was in compliance with its financial covenants. |
Acquisition (Tables)
Acquisition (Tables) - RITEC [Member] | 6 Months Ended |
Aug. 01, 2015 | |
Purchase Price of Acquisition Allocated on Basis of Fair Value | The purchase price of the acquisition has been allocated on the basis of the fair value as follows: (In thousands) Accounts Receivable $ 50 Identifiable Intangible Assets 3,780 Goodwill 3,530 Total Purchase Price $ 7,360 |
Fair Value of the Acquired Identifiable Intangible Assets and Related Estimated Useful Lives | The following table reflects the fair value of the acquired identifiable intangible assets and related estimated useful lives: (In thousands) Fair Value Useful Life Customer Contract Relationships $ 2,830 10 Non-Compete Agreement 950 5 Total $ 3,780 |
Net Income Per Common Share (Ta
Net Income Per Common Share (Tables) | 6 Months Ended |
Aug. 01, 2015 | |
Earnings Per Share [Abstract] | |
Reconciliation of Shares Used in Calculating Basic and Diluted | A reconciliation of the shares used in calculating basic and diluted net income per share is as follows: Three Months Ended Six Months Ended August 1, August 2, August 1, August 2, Weighted Average Common Shares Outstanding—Basic 7,278,329 7,703,782 7,268,745 7,652,000 Effect of Dilutive Options, Restricted Stock Awards and Restricted Stock Units 190,934 212,176 190,676 230,706 Weighted Average Common Shares Outstanding—Diluted 7,469,263 7,915,958 7,459,421 7,882,706 |
Intangible Assets (Tables)
Intangible Assets (Tables) | 6 Months Ended |
Aug. 01, 2015 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Fair Value of Acquired Identifiable Intangible Assets and Related Estimated Useful Lives | Intangible assets are as follows: August 1, 2015 January 31, 2015 ($ In thousands) Gross Accumulated Net Gross Accumulated Net Intangible assets subject to amortization: Customer Contract Relationships (Miltope) $ 3,100 (580 ) $ 2,520 $ 3,100 $ (402 ) $ 2,698 Customer Contract Relationships (RITEC) 2,830 — 2,830 — — — Non-Compete Agreement (RITEC) 950 (16 ) 934 — — — Intangible assets, net $ 6,880 $ (596 ) $ 6,284 $ 3,400 $ (702 ) $ 2,698 |
Summary of Estimated Amortization Expense | Estimated amortization expense for the next five years is as follows: (In thousands) Remainder of 2016 2017 2018 2019 2020 Estimated amortization expenses $ 305 $ 715 $ 774 $ 769 $ 802 |
Share-Based Compensation (Table
Share-Based Compensation (Tables) | 6 Months Ended |
Aug. 01, 2015 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Share-Based Compensation Expense | Share-based compensation expense was recognized as follows: Three Months Ended Six Months Ended August 1, August 2, August 1, August 2, (In thousands) Stock Options $ 70 $ 59 $ 144 $ 112 Restricted Stock Awards and Restricted Stock Units 228 67 296 144 Employee Stock Purchase Plan 3 2 4 3 Total $ 301 $ 128 $ 444 $ 259 |
Fair Value of Stock Options Granted | The fair value of stock options granted during the six months ended August 1, 2015 and August 2, 2014 was estimated using the following assumptions: August 1, August 2, Risk Free Interest Rate 1.6 % 1.6 % Expected Volatility 22.7 % 26.8 % Expected Life (in years) 5.0 5.0 Dividend Yield 2.0 % 2.0 % |
Aggregated Information Regarding Stock Options Granted | Aggregated information regarding stock options granted under the Plans for the six months ended August 1, 2015 is summarized below: Number of Options Weighted Average Weighted Average Aggregate Intrinsic Outstanding at January 31, 2015 656,011 $ 10.01 4.2 $ 3,225,000 Granted 110,000 13.98 Exercised (20,979 ) 8.24 Expired or canceled (2,093 ) 7.93 Forfeited (700 ) 12.61 Outstanding at August 1, 2015 742,239 $ 10.65 6.1 $ 2,396,104 Exercisable at August 1, 2015 475,776 $ 9.41 4.6 $ 2,109,647 |
Aggregated Information Regarding RSUs and RSAs Granted | Aggregated information regarding RSUs and RSAs granted under the Plan for the six months ended August 1, 2015 is summarized below: RSAs & RSUs Weighted Average Unvested at January 31, 2015 72,245 $ 9.70 Granted 244,072 14.05 Vested (8,665 ) 13.95 Forfeited (2,800 ) 10.07 Unvested at August 1, 2015 304,852 $ 13.06 |
Inventories (Tables)
Inventories (Tables) | 6 Months Ended |
Aug. 01, 2015 | |
Inventory Disclosure [Abstract] | |
Components of Inventories | The components of inventories are as follows: August 1, 2015 January 31, 2015 (In thousands) Materials and Supplies $ 9,962 $ 10,600 Work-In-Process 816 765 Finished Goods 6,900 7,372 17,678 18,737 Inventory Reserve (3,741 ) (3,155 ) $ 13,937 $ 15,582 |
Income Taxes (Tables)
Income Taxes (Tables) | 6 Months Ended |
Aug. 01, 2015 | |
Income Tax Disclosure [Abstract] | |
Projected Effective Tax Rate for Periods | The Company’s effective tax rates for the period, which are based on the projected effective tax rate for the full year, are as follows: Three Months Ended Six Months Ended Fiscal 2016 37.0 % 32.7 % Fiscal 2015 36.1 % 33.0 % |
Segment Information (Tables)
Segment Information (Tables) | 6 Months Ended |
Aug. 01, 2015 | |
Segment Reporting [Abstract] | |
Net Sales and Segment Operating Profit for Each Reporting Segment | Summarized below are the Net Sales and Segment Operating Profit for each reporting segment: Three Months Ended Six Months Ended Net Sales Segment Operating Profit Net Sales Segment Operating Profit (In thousands) August 1, August 2, August 1, August 2, August 1, August 2, August 1, August 2, QuickLabel $ 17,100 $ 15,257 $ 2,720 $ 2,247 $ 32,744 $ 29,680 $ 4,698 $ 4,445 T&M 6,838 7,109 897 1,360 13,400 13,460 1,825 2,052 Total $ 23,938 $ 22,366 3,617 3,607 $ 46,144 $ 43,140 6,523 6,497 Corporate Expenses 1,783 1,443 3,241 2,634 Operating Income 1,834 2,164 3,282 3,863 Other Income (Expense)—Net 21 83 254 (38 ) Income Before Income Taxes 1,855 2,247 3,536 3,825 Income Tax Provision 687 812 1,158 1,261 Net Income $ 1,168 $ 1,435 $ 2,378 $ 2,564 |
Securities Available for Sale (
Securities Available for Sale (Tables) | 6 Months Ended |
Aug. 01, 2015 | |
Investments, Debt and Equity Securities [Abstract] | |
Fair Value, Amortized Cost and Gross Unrealized Gains and Losses of the Securities | The fair value, amortized cost and gross unrealized gains and losses of securities available for sale are as follows: (In thousands) August 1, 2015 Amortized Cost Gross Unrealized Gross Unrealized Fair Value State and Municipal Obligations $ 13,273 $ 10 $ (9 ) $ 13,274 January 31, 2015 Amortized Cost Gross Unrealized Gross Unrealized Fair Value State and Municipal Obligations $ 15,150 $ 26 $ (2 ) $ 15,174 |
Fair Value (Tables)
Fair Value (Tables) | 6 Months Ended |
Aug. 01, 2015 | |
Fair Value Disclosures [Abstract] | |
Assets Measured at Fair Value on a Recurring Basis | Assets measured at fair value on a recurring basis are summarized below: (In thousands) August 1, 2015 Level 1 Level 2 Level 3 Total Money Market Funds (included in Cash and Cash Equivalents) $ 1,363 $ — $ — $ 1,363 State and Municipal Obligations (included in Securities Available for Sale) — 13,274 — 13,274 Total $ 1,363 $ 13,274 $ — $ 14,637 January 31, 2015 Level 1 Level 2 Level 3 Total Money Market Funds (included in Cash and Cash Equivalents) $ 3,028 $ — $ — $ 3,028 State and Municipal Obligations (included in Securities Available for Sale) — 15,174 — 15,174 Total $ 3,028 $ 15,174 $ — $ 18,202 |
Accumulated Other Comprehensi33
Accumulated Other Comprehensive Loss (Tables) | 6 Months Ended |
Aug. 01, 2015 | |
Equity [Abstract] | |
Changes in the Balance of Accumulated Other Comprehensive Income (Loss) | The changes in the balance of accumulated other comprehensive income (loss) by component are as follows: (In thousands) Foreign Currency Unrealized Holding Gain Total Balance at January 31, 2015 $ (714 ) $ 15 $ (699 ) Other Comprehensive Income (Loss) (113 ) (15 ) (128 ) Balance at August 1, 2015 $ (827 ) $ — $ (827 ) |
Acquisition - Additional Inform
Acquisition - Additional Information (Detail) - Aug. 01, 2015 - USD ($) | Total |
Business Acquisition [Line Items] | |
Fair value assumptions, Weighted average cost of capital | 15.50% |
Fair value key assumptions | Key assumptions include (1) a weighted average cost of capital of 15.5%; (2) a range of earnings projections from $110,000-$700,000 and (3) a range of contract renewal probability from 0%-100%. |
Minimum [Member] | |
Business Acquisition [Line Items] | |
Fair value assumptions, Earnings projections | $ 110,000 |
Fair value assumptions, Contract renewal probability | 0.00% |
Maximum [Member] | |
Business Acquisition [Line Items] | |
Fair value assumptions, Earnings projections | $ 700,000 |
Fair value assumptions, Contract renewal probability | 100.00% |
RITEC [Member] | |
Business Acquisition [Line Items] | |
Completion date of acquisition | Jun. 19, 2015 |
Date of asset purchase agreement | Jun. 18, 2015 |
Purchase price of the acquisition | $ 7,360,000 |
Amount held in escrow related to business acquisition | $ 750,000 |
Duration of escrow deposits | 12 months |
General and administrative expenses | $ 90,000 |
Estimated inventory purchase | $ 100,000 |
Percentage of royalties on sale price of products | 7.50% |
Initial royalty payment period | 5 years |
Goodwill deductible for tax purposes | $ 3,530,000 |
Acquisition - Purchase Price of
Acquisition - Purchase Price of Acquisition Allocated on Basis of Fair Value (Detail) - USD ($) $ in Thousands | Aug. 01, 2015 | Jun. 19, 2015 | Jan. 31, 2015 |
Business Acquisition [Line Items] | |||
Goodwill | $ 4,522 | $ 991 | |
RITEC [Member] | |||
Business Acquisition [Line Items] | |||
Accounts Receivable | $ 50 | ||
Identifiable Intangible Assets | $ 3,780 | 3,780 | |
Goodwill | 3,530 | ||
Total Purchase Price | $ 7,360 |
Acquisition - Fair Value of the
Acquisition - Fair Value of the Acquired Identifiable Intangible Assets and Related Estimated Useful Lives (Detail) - RITEC [Member] - USD ($) $ in Thousands | 6 Months Ended | |
Aug. 01, 2015 | Jun. 19, 2015 | |
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Fair Value | $ 3,780 | $ 3,780 |
Customer Contract Relationships [Member] | ||
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Fair Value | $ 2,830 | |
Useful Life | 10 years | |
Non-Compete Agreement [Member] | ||
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Fair Value | $ 950 | |
Useful Life | 5 years |
Net Income Per Common Share - R
Net Income Per Common Share - Reconciliation of Shares Used in Calculating Basic and Diluted (Detail) - shares | 3 Months Ended | 6 Months Ended | ||
Aug. 01, 2015 | Aug. 02, 2014 | Aug. 01, 2015 | Aug. 02, 2014 | |
Earnings Per Share [Abstract] | ||||
Weighted Average Common Shares Outstanding-Basic | 7,278,000 | 7,704,000 | 7,269,000 | 7,652,000 |
Effect of Dilutive Options, Restricted Stock Awards and Restricted Stock Units | 190,934 | 212,176 | 190,676 | 230,706 |
Weighted Average Common Shares Outstanding-Diluted | 7,469,000 | 7,916,000 | 7,459,000 | 7,883,000 |
Net Income Per Common Share - A
Net Income Per Common Share - Additional Information (Detail) - shares | 3 Months Ended | 6 Months Ended | ||
Aug. 01, 2015 | Aug. 02, 2014 | Aug. 01, 2015 | Aug. 02, 2014 | |
Earnings Per Share [Abstract] | ||||
Number of common equivalent shares | 424,100 | 150,000 | 424,100 | 150,000 |
Intangible Assets - Fair Value
Intangible Assets - Fair Value of Acquired Identifiable Intangible Assets and Related Estimated Useful Lives (Detail) - USD ($) $ in Thousands | Aug. 01, 2015 | Jan. 31, 2015 |
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | $ 6,880 | $ 3,400 |
Accumulated Amortization | (596) | (702) |
Net Carrying Amount | 6,284 | 2,698 |
Customer Contract Relationships [Member] | Miltope [Member] | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 3,100 | 3,100 |
Accumulated Amortization | (580) | (402) |
Net Carrying Amount | 2,520 | $ 2,698 |
Customer Contract Relationships [Member] | RITEC [Member] | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 2,830 | |
Net Carrying Amount | 2,830 | |
Non-Compete Agreement [Member] | RITEC [Member] | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 950 | |
Accumulated Amortization | (16) | |
Net Carrying Amount | $ 934 |
Intangible Assets - Additional
Intangible Assets - Additional Information (Detail) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Aug. 01, 2015 | Aug. 02, 2014 | Aug. 01, 2015 | Aug. 02, 2014 | |
Impairment of Intangible Assets (Excluding Goodwill) [Abstract] | ||||
Impairments of intangible assets | $ 0 | $ 0 | ||
Amortization expense | $ 105,000 | $ 175,000 | $ 194,000 | $ 351,000 |
Intangible Assets - Summary of
Intangible Assets - Summary of Estimated Amortization Expense (Detail) $ in Thousands | Aug. 01, 2015USD ($) |
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] | |
Remainder of 2016 | $ 305 |
2,017 | 715 |
2,018 | 774 |
2,019 | 769 |
2,020 | $ 802 |
Share-Based Compensation - Addi
Share-Based Compensation - Additional Information (Detail) | Aug. 01, 2014USD ($) | Feb. 01, 2014shares | May. 31, 2015Installmentshares | Mar. 31, 2015Installmentshares | Aug. 01, 2015USD ($)$ / sharesshares | May. 02, 2015$ / sharesshares | Aug. 02, 2014$ / sharesshares | May. 03, 2014$ / shares | Aug. 01, 2015USD ($)Equity_Planshares |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Reservation of shares under Stock Purchase Plan | 247,500 | ||||||||
Number of equity incentive plan | Equity_Plan | 2 | ||||||||
Maximum disposal restricted percentage of RSU | 50.00% | ||||||||
Number of options, granted | 110,000 | ||||||||
Restricted stocks, granted | 244,072 | ||||||||
Non-employee director is entitled to an annual cash retainer | $ | $ 7,000 | ||||||||
Non-employee director received restricted stock award value | $ | $ 7,115 | $ 20,000 | |||||||
Options granted weighted average fair value per share | $ / shares | $ 2.44 | $ 2.43 | $ 2.84 | $ 2.93 | |||||
2007 Equity Incentive Plan [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Incentive plan, expiration period | 2017-05 | ||||||||
Shares available for grant under the Plan | 107,874 | 107,874 | |||||||
Reservation of shares under Stock Purchase Plan | 100,000 | ||||||||
2015 Equity Incentive Plan [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Incentive plan, expiration period | 2025-05 | ||||||||
Shares available for grant under the Plan | 240,000 | 240,000 | |||||||
Employee Stock Purchase Plan [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Shares available for grant under the Plan | 54,980 | 54,980 | |||||||
Employee Stock Purchase Plan discount rate | 15.00% | ||||||||
Shares purchase under Employee Stock Purchase Plan | 1,293 | 1,592 | |||||||
Maximum [Member] | 2015 Equity Incentive Plan [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Maximum number of shares of common stock of the Company authorized for issuance | 500,000 | 500,000 | |||||||
Non-Employee Director [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Number of options, granted | 25,000 | ||||||||
Non-employee director is entitled to an annual cash retainer additional | $ | $ 500 | ||||||||
Chairman of Board [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Amount of Chair Retainer payable | $ | $ 6,000 | ||||||||
Chair of Audit Committee [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Amount of Chair Retainer payable | $ | 4,000 | ||||||||
Chair of Compensation Committee [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Amount of Chair Retainer payable | $ | $ 4,000 | ||||||||
Chief Executive Officer [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Number of options, granted | 50,000 | ||||||||
Other Key Employees [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Number of options, granted | 35,000 | ||||||||
RSA [Member] | Non-Employee Director [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Award vesting period | 12 months | ||||||||
RSA [Member] | Chief Executive Officer [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Restricted stocks, granted | 537 | ||||||||
Stock Options [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Unrecognized compensation expense related to unvested options | $ | $ 577,000 | $ 577,000 | |||||||
Unrecognized compensation expense related to unvested options, recognize date | Through March 2019 | ||||||||
Stock Options [Member] | 2007 Equity Incentive Plan [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Award vesting period | 4 years | ||||||||
Option expiration period | 10 years | ||||||||
Stock Options [Member] | 2015 Equity Incentive Plan [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Award vesting period | 4 years | ||||||||
Option expiration period | 10 years | ||||||||
2013 Restricted Stock Units (RSUs) [Member] | First Anniversary [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Restricted stock unit vested percentage | 50.00% | ||||||||
2013 Restricted Stock Units (RSUs) [Member] | Second Anniversary [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Restricted stock unit vested percentage | 50.00% | ||||||||
2014 Restricted Stock Units (RSUs) [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Number of accelerated vesting shares | 4,166 | 0 | |||||||
Unrecognized compensation expense related to unvested options, recognize date | Through May 2019 | ||||||||
Unrecognized compensation expense related to unvested RSUs and RSAs | $ | $ 1,658,000 | $ 1,658,000 | |||||||
2014 Restricted Stock Units (RSUs) [Member] | Officer [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Cumulative budgeted net sales target measurement period | 2014 through 2016 | ||||||||
2014 Restricted Stock Units (RSUs) [Member] | Officer [Member] | Net Sales Target [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Restricted stock unit vested percentage | 50.00% | ||||||||
2014 Restricted Stock Units (RSUs) [Member] | Officer [Member] | ORONA Target [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Restricted stock unit vested percentage | 25.00% | ||||||||
2014 Restricted Stock Units (RSUs) [Member] | Officer [Member] | Third Anniversary [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Restricted stock unit vested percentage | 25.00% | ||||||||
Equity Incentive Plan [Member] | Non-Employee Director [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Option expiration period | 10 years | ||||||||
Number of options, granted | 5,000 | ||||||||
Number of stock options grant to each non-employee director | 722 | 698 | |||||||
Restricted Stock And Stock Option [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Number of annual vesting installments | Installment | 4 | ||||||||
Time Based RSUs [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Restricted stocks, granted | 80,000 | ||||||||
Number of annual vesting installments | Installment | 4 | ||||||||
Performance Based RSUs [Member] | |||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Award vesting period | 3 years | ||||||||
Restricted stocks, granted | 155,000 |
Share-Based Compensation - Shar
Share-Based Compensation - Share-Based Compensation Expense (Detail) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Aug. 01, 2015 | Aug. 02, 2014 | Aug. 01, 2015 | Aug. 02, 2014 | |
Share-based Compensation [Abstract] | ||||
Stock Options | $ 70 | $ 59 | $ 144 | $ 112 |
Restricted Stock Awards and Restricted Stock Units | 228 | 67 | 296 | 144 |
Employee Stock Purchase Plan | 3 | 2 | 4 | 3 |
Total | $ 301 | $ 128 | $ 444 | $ 259 |
Share-Based Compensation - Fair
Share-Based Compensation - Fair Value of Stock Options Granted (Detail) | 6 Months Ended | |
Aug. 01, 2015 | Aug. 02, 2014 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ||
Risk Free Interest Rate | 1.60% | 1.60% |
Expected Volatility | 22.70% | 26.80% |
Expected Life (in years) | 5 years | 5 years |
Dividend Yield | 2.00% | 2.00% |
Share-Based Compensation - Aggr
Share-Based Compensation - Aggregated Information Regarding Stock Options Granted (Detail) - USD ($) | 6 Months Ended | 12 Months Ended |
Aug. 01, 2015 | Jan. 31, 2015 | |
Share-based Compensation [Abstract] | ||
Beginning balance, Number of Options | 656,011 | |
Granted, Number of Options | 110,000 | |
Exercised, Number of Options | (20,979) | |
Expired or canceled, Number of Options | (2,093) | |
Forfeited, Number of Options | (700) | |
Ending balance, Number of Options | 742,239 | 656,011 |
Exercisable, Number of Options | 475,776 | |
Beginning balance, Weighted Average Exercise Price | $ 10.01 | |
Granted, Weighted Average Exercise Price | 13.98 | |
Exercised, Weighted Average Exercise Price | 8.24 | |
Expired or canceled, Weighted Average Exercise Price | 7.93 | |
Forfeited, Weighted Average Exercise Price | 12.61 | |
Ending balance, Weighted Average Exercise Price | 10.65 | $ 10.01 |
Exercisable, Weighted Average Exercise Price | $ 9.41 | |
Weighted Average Remaining Contractual Life (in Years) | 6 years 1 month 6 days | 4 years 2 months 12 days |
Exercisable, Weighted Average Remaining Contractual Life (in Years) | 4 years 7 months 6 days | |
Beginning balance, Aggregated Intrinsic Value | $ 3,225,000 | |
Ending balance, Aggregated Intrinsic Value | 2,396,104 | |
Exercisable, Aggregate Intrinsic Value | $ 2,109,647 | $ 3,225,000 |
Share-Based Compensation - Ag46
Share-Based Compensation - Aggregated Information Regarding RSUs and RSAs Granted (Detail) - 6 months ended Aug. 01, 2015 - $ / shares | Total |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Beginning balance, Unvested Restricted Stock Units and Restricted Stock Awards | 72,245 |
Granted, Restricted Stock Units and Restricted Stock Awards | 244,072 |
Vested, Restricted Stock Units and Restricted Stock Awards | (8,665) |
Forfeited, Restricted Stock Units and Restricted Stock Awards | (2,800) |
Ending balance, Unvested Restricted Stock Units and Restricted Stock Awards | 304,852 |
Beginning balance, Weighted Average Grant Date Fair Value | $ 9.70 |
Granted, Weighted Average Grant Date Fair Value | 14.05 |
Vested, Weighted Average Grant Date Fair Value | 13.95 |
Forfeited, Weighted Average Grant Date Fair Value | 10.07 |
Ending balance, Weighted Average Grant Date Fair Value | $ 13.06 |
Inventories - Components of Inv
Inventories - Components of Inventories (Detail) - USD ($) $ in Thousands | Aug. 01, 2015 | Jan. 31, 2015 |
Inventory Disclosure [Abstract] | ||
Materials and Supplies | $ 9,962 | $ 10,600 |
Work-In-Process | 816 | 765 |
Finished Goods | 6,900 | 7,372 |
Inventory, Gross | 17,678 | 18,737 |
Inventory Reserve | (3,741) | (3,155) |
Total Inventory | $ 13,937 | $ 15,582 |
Income Taxes - Projected Effect
Income Taxes - Projected Effective Tax Rate for Periods (Detail) | 3 Months Ended | 6 Months Ended | ||
Aug. 01, 2015 | Aug. 02, 2014 | Aug. 01, 2015 | Aug. 02, 2014 | |
Income Tax Disclosure [Abstract] | ||||
Effective tax rates for income from continuing operations | 37.00% | 36.10% | 32.70% | 33.00% |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Detail) - USD ($) | 3 Months Ended | 6 Months Ended | |||
Aug. 01, 2015 | Aug. 02, 2014 | Aug. 01, 2015 | Aug. 02, 2014 | Jan. 31, 2015 | |
Income Tax Disclosure [Abstract] | |||||
Income tax expense | $ 687,000 | $ 812,000 | $ 1,158,000 | $ 1,261,000 | |
Income tax expense (benefit) related to prior year's state taxes | (135,000) | $ (100,000) | |||
Cumulative unrecognized tax benefits | $ 643,000 | 643,000 | $ 707,000 | ||
Developments affecting unrecognized tax benefits | $ 0 |
Note Receivable and Line of C50
Note Receivable and Line of Credit Issued - Additional Information (Detail) | Jan. 30, 2012USD ($) | Aug. 01, 2015USD ($)Installment |
Debt Disclosure [Abstract] | ||
Net sale price | $ 1,000,000 | |
Promissory note interest rate | 3.75% | |
Interest commencement date | Jan. 30, 2013 | |
Interest installments | Installment | 16 | |
Promissory note outstanding | $ 319,000 | |
Revolving line of credit issued maximum | $ 600,000 | |
Interest rate on outstanding credit balance | 2.00% | |
Line of credit facility maturity date | Jan. 31, 2016 | |
Extended revolving line of credit | $ 150,000 |
Segment Information - Additiona
Segment Information - Additional Information (Detail) | 6 Months Ended |
Aug. 01, 2015Segment | |
Segment Reporting [Abstract] | |
Number of reporting segments | 2 |
Segment Information - Net Sales
Segment Information - Net Sales and Segment Operating Profit for Each Reporting Segment (Detail) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Aug. 01, 2015 | Aug. 02, 2014 | Aug. 01, 2015 | Aug. 02, 2014 | |
Segment Reporting Information [Line Items] | ||||
Net Sales | $ 23,938 | $ 22,366 | $ 46,144 | $ 43,140 |
Corporate Expenses | 1,783 | 1,443 | 3,241 | 2,634 |
Operating Income | 1,834 | 2,164 | 3,282 | 3,863 |
Other Income (Expense)-Net | 21 | 83 | 254 | (38) |
Income Before Income Taxes | 1,855 | 2,247 | 3,536 | 3,825 |
Income Tax Provision | 687 | 812 | 1,158 | 1,261 |
Net Income | 1,168 | 1,435 | 2,378 | 2,564 |
Operating Segments [Member] | ||||
Segment Reporting Information [Line Items] | ||||
Operating Income | 3,617 | 3,607 | 6,523 | 6,497 |
Operating Segments [Member] | QuickLabel [Member] | ||||
Segment Reporting Information [Line Items] | ||||
Net Sales | 17,100 | 15,257 | 32,744 | 29,680 |
Operating Income | 2,720 | 2,247 | 4,698 | 4,445 |
Operating Segments [Member] | T&M [Member] | ||||
Segment Reporting Information [Line Items] | ||||
Net Sales | 6,838 | 7,109 | 13,400 | 13,460 |
Operating Income | 897 | 1,360 | 1,825 | 2,052 |
Corporate Expenses [Member] | ||||
Segment Reporting Information [Line Items] | ||||
Corporate Expenses | $ 1,783 | $ 1,443 | $ 3,241 | $ 2,634 |
Securities Available for Sale -
Securities Available for Sale - Additional Information (Detail) - 6 months ended Aug. 01, 2015 - USD ($) | Total |
Schedule of Available-for-sale Securities [Line Items] | |
Impairment charges on available for sale security | $ 0 |
Minimum [Member] | |
Schedule of Available-for-sale Securities [Line Items] | |
Original maturity of short-term investments | 90 days |
Anticipated maturity period | 1 month |
Maximum [Member] | |
Schedule of Available-for-sale Securities [Line Items] | |
Anticipated maturity period | 31 months |
Securities Available for Sale54
Securities Available for Sale - Fair Value, Amortized Cost and Gross Unrealized Gains and Losses of the Securities (Detail) - USD ($) $ in Thousands | 6 Months Ended | 12 Months Ended |
Aug. 01, 2015 | Jan. 31, 2015 | |
Schedule of Available-for-sale Securities [Line Items] | ||
Fair Value | $ 13,274 | $ 15,174 |
State and Municipal Obligations [Member] | ||
Schedule of Available-for-sale Securities [Line Items] | ||
Amortized Cost | 13,273 | 15,150 |
Gross Unrealized Gains | 10 | 26 |
Gross Unrealized Losses | (9) | (2) |
Fair Value | $ 13,274 | $ 15,174 |
Fair Value - Assets Measured at
Fair Value - Assets Measured at Fair Value on a Recurring Basis (Detail) - USD ($) $ in Thousands | Aug. 01, 2015 | Jan. 31, 2015 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Money Market Funds (included in Cash and Cash Equivalents) | $ 1,363 | $ 3,028 |
State and Municipal Obligations (included in Securities Available for Sale) | 13,274 | 15,174 |
Total | 14,637 | 18,202 |
Level 1 [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Money Market Funds (included in Cash and Cash Equivalents) | 1,363 | 3,028 |
Total | 1,363 | 3,028 |
Level 2 [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
State and Municipal Obligations (included in Securities Available for Sale) | 13,274 | 15,174 |
Total | $ 13,274 | $ 15,174 |
Accumulated Other Comprehensi56
Accumulated Other Comprehensive Loss - Changes in the Balance of Accumulated Other Comprehensive Income (Loss) (Detail) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Aug. 01, 2015 | Aug. 02, 2014 | Aug. 01, 2015 | Aug. 02, 2014 | |
Schedule of Capitalization, Equity [Line Items] | ||||
Beginning Balance | $ (699) | |||
Other Comprehensive Income (Loss) | $ (118) | $ (132) | (128) | $ (43) |
Ending Balance | (827) | (827) | ||
Foreign Currency Translation Adjustments [Member] | ||||
Schedule of Capitalization, Equity [Line Items] | ||||
Beginning Balance | (714) | |||
Other Comprehensive Income (Loss) | (113) | |||
Ending Balance | $ (827) | (827) | ||
Unrealized Holding Gain on Available for Sale Securities [Member] | ||||
Schedule of Capitalization, Equity [Line Items] | ||||
Beginning Balance | 15 | |||
Other Comprehensive Income (Loss) | $ (15) |
Commitments and Contingencies -
Commitments and Contingencies - Additional Information (Detail) - USD ($) | 1 Months Ended | 3 Months Ended | 6 Months Ended |
Jan. 31, 2014 | May. 04, 2013 | Aug. 01, 2015 | |
Commitments and Contingencies Disclosure [Abstract] | |||
Estimated replacement cost | $ 672,000 | ||
Replacement cost charged against reserve | $ 358,000 | ||
Other accrued expenses | $ 314,000 | ||
Amount received from supplier for recovery | $ 450,000 | ||
Lower product prices period | Through fiscal 2017 |
Line of Credit - Additional Inf
Line of Credit - Additional Information (Detail) - Aug. 01, 2015 - USD ($) | Total |
Line of Credit Facility [Line Items] | |
Revolving line of credit | $ 10,000,000 |
Agreement term | 3 years |
Line of credit, interest rate description | Any borrowings made under this line of credit bear interest at either a fluctuating base rate equal to the highest of (i) the Prime Rate, (ii) 1.50% above the daily one month LIBOR, and (iii) the Federal Funds Rate in effect plus 1.50% or at a fixed rate of LIBOR plus an agreed upon margin of between 0% and 2.25%, based on the Company's funded debt to EBITDA ratio as defined in the agreement. |
Borrowings against new line of credit | $ 0 |
Fixed Charge Coverage Ratio | 300.00% |
Funded debt to adjusted EBITDA ratio | 125.00% |
London Interbank Offered Rate (LIBOR) [Member] | |
Line of Credit Facility [Line Items] | |
Percentage above rate | 1.50% |
London Interbank Offered Rate (LIBOR) [Member] | Minimum [Member] | |
Line of Credit Facility [Line Items] | |
Percentage above rate | 0.00% |
London Interbank Offered Rate (LIBOR) [Member] | Maximum [Member] | |
Line of Credit Facility [Line Items] | |
Percentage above rate | 2.25% |
Federal Funds Effective Swap Rate [Member] | |
Line of Credit Facility [Line Items] | |
Percentage above rate | 1.50% |